echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Contraceptive antibodies are here!

    Contraceptive antibodies are here!

    • Last Update: 2021-08-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Pro

    Author: Li Yuan

    Traditional contraceptive methods include physical barriers and hormonal drugs.
    These methods have their own advantages and disadvantages.
    In particular, hormonal drugs have side effects such as depression, nausea, and migraine
    .

    In view of the fact that the core of almost all contraceptive methods is to prevent the combination of sperm and eggs, if sperm are regarded as foreign invaders that interfere with normal body function, can the development of contraceptive methods be carried out by capturing sperm antigens?

    In fact, the concept of sperm antibodies has not been proposed for the first time.
    Previous studies have found that some women's bodies naturally produce sperm antibodies, which can lead to infertility
    .
    The team of Dr.


    Samuel Lai of the University of North Carolina’s Eshelman School of Pharmacy has been studying the antigen-binding fragments (Fab) of these antibodies for many years


    In a new study published in Science Translational Medicine on August 11, the research team introduced an antibody that recognizes human sperm-specific antigens that can bind to and capture over 99% of human sperm in the vagina of sheep
    .
    Researchers also founded a company (Mucommune) to continue the development of such antibody contraceptives


    .


    The original IgG antibody has only two antigen-binding fragments.
    In this new study, the researchers designed a group of multivalent IgG (HM-IgG) with 6-10 antigen-binding fragments, namely FIF (6-Fab HM).
    -IgG), FIFF (8-Fab HM-IgG) and FFIFF (10-FabHM-IgG)
    .
    These antigen-binding fragments are isolated from sperm antibodies in an immunized infertile woman and can specifically target the CD52g antigen.


    CD52g is present in almost all human sperm, but it does not contain this antigen in other human tissues and women


    Production and characterization of multivalent sperm antibodies (Source: Science Translational Medicine)

    The researchers first tested the ability of HM-IgG to immobilize sperm in vitro.
    They found that HM-IgG with additional antigen-binding fragments had at least 10 to 16 times higher sperm agglutination efficiency than original IgG with only two antigen-binding fragments, and the speed Faster
    .

    Multimerization enhances the agglutination efficiency of anti-sperm IgG antibodies (Source: Science Translational Medicine)

    Since CD52g is only found in the sperm of humans and chimpanzees, there is currently no practical animal model to conduct mating-based contraceptive studies, and the sheep vagina is very similar in physiology and anatomy to the human vagina, and the researchers designed accordingly A study of sheep
    .

    The research procedure is to first inject phosphate buffered saline (PBS), IgG, 6-Fab HM-IgG or 10-Fab HM-IgG into the vagina of female sheep, and then carry out simulated mating and vaginal infusion of human semen samples.
    Two minutes after the semen instillation, a semen sample was retrieved for analysis of sperm motility
    .

    The results show that at high doses (333 μg), almost all sperm motility can be effectively inhibited by the three antibodies
    .
    At low doses (33.


    3 μg), 6-Fab HM-IgG and 10-Fab HM-IgG can still capture 97% and more than 99% of sperm


    In in vivo studies, multivalent anti-sperm IgG showed stronger agglutination efficiency than original IgG (Source: Science Translational Medicine)

    Of course, if this sperm antibody is to be introduced into the clinic, there are still some problems that need to be resolved
    .
    For example, because this study did not directly prove the effectiveness of antibodies by preventing pregnancy, subsequent research and development also need to determine the success rate of antibodies in this regard, in addition to the similarity between sheep and human vaginal mucus and its influence on the experimental results.


    and so on


    The current focus of the research team is to integrate antibodies into the vaginal membrane or ring for contraception during pregnancy
    .
    Dr.


    Samuel Lai said that in the future, different drug delivery methods can also be developed according to the different needs of women


    Reference materials:

    [1] Bhawana S.


    [2] Antibodies Stop Sperm in Their Tracks (Source: TheScientist)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.